All Sauce from Weekly Gravy:

Low-dose aspirin may help some people curb their risk of developing colon cancer — but not if they wait until age 70 to start, a large, new study suggests. Researchers found that when people began using aspirin in their 50s or 60s, their risk of developing colon cancer after age 70 was trimmed by 20%. There was no such benefit, however, among people who began using aspirin at age 70 or later. No one is saying all middle-aged people should rush to take low-dose aspirin, experts cautioned. In fact, the U.S. Preventive Services Task Force recommends low-dose aspirin (usually 81 mg a day) for only a select group: People in their 50s who have at least a 10% risk of suffering a heart attack or stroke in the next 10 years. The rationale is that long-term aspirin use carries a risk of bleeding in the gut or the brain. But for those middle-aged adults, the risk is outweighed by the benefits — namely, reduced odds of both cardiovascular disease and colon cancer. With older adults, the benefits of starting aspirin are less clear. So the task force — a government-funded panel of medical experts — suggests people in their 60s talk to their doctor about the pros and cons. For people in their 70s, the aspirin question gets murkier. And a 2018 clinical trial fueled…  read on >  read on >

Talk therapy for new mothers with postpartum depression may also benefit their babies’ brains, Canadian researchers say. “We found that after their moms were treated that their infant’s brain activity normalized to the levels seen in our healthy infants,” said study co-author Ryan Van Lieshout, an associate professor of psychiatry and behavioral neuroscience at McMaster University in Hamilton, Ontario. The study included 40 infants of women with postpartum depression and 40 infants of non-depressed mothers. The mothers with postpartum depression received nine weeks of group cognitive behavioral therapy. This type of therapy aims to help patients change destructive thought patterns. Their infants were assessed before therapy began and nine weeks later. That included having mothers and their partners complete a questionnaire on their infants’ behavior. Cognitive behavioral therapy not only helped the mothers, but also led to improvements in their infants’ nervous and cardiovascular systems, as well as their emotions and behavior, according to the researchers. It is known that children of women with postpartum depression have changes in brain function that increase their risk of emotional and behavioral problems later in life, but it wasn’t known if treating the mother’s postpartum depression could reduce the risk. “We believe that this is the first time that anyone has shown that treating moms’ postpartum depression can lead to healthy changes in the physiology of the brains…  read on >  read on >

The explosive rise in use of alcohol-based hand sanitizers during the COVID-19 pandemic has had a dangerous, unintended consequence: eye injuries among children. Using data from French poison control and a children’s hospital in Paris, researchers reported that accidental eye injuries to kids under age 18 shot up sevenfold during a five-month period last year, compared to 2019. Eye injury due to hand sanitizer exposure “is a known complication,” said Dr. Sonal Tuli, a clinical spokeswoman for the American Academy of Ophthalmology (AAO) who reviewed the study findings. “This is a concern not just for children but also adults and health care workers,” Tuli said. “To my knowledge, there have been no recent similar studies in the U.S., but I suspect there are similar injuries occurring here, too.” The new study was published online Jan. 21 in JAMA Ophthalmology. Hand sanitizers consist mainly of ethanol or isopropyl alcohol (60% to 95%), which are toxic to delicate structures like eyes, noted Dr. Sonam Yangzes, a consultant in the division of lens, cornea and refractive services for the Grewal Eye Institute in Chandigarh, India. As such, exposure to sanitizers “may lead to blindness, due to development of corneal ulcer or melt,” said Yangzes, who co-wrote an editorial that accompanied the study. Increased use of the products during the COVID-19 pandemic has made “children more vulnerable to eye…  read on >  read on >

Irene Greenhalgh, 83, considers herself a pretty computer-savvy senior, but even she got lost in a maze of websites and e-mails trying to get an appointment for her COVID-19 vaccine. One health provider’s e-mail provided links to sites that were giving vaccinations, but the dates listed were a week old. A board of health’s website proved glitchy and unusable. After weeks of searching, Greenhalgh finally got an appointment, but it’s more than two months away and she’ll have to travel about 13 miles from her home in Amityville, N.Y., to Jones Beach for her first shot. “I had a hard time,” Greenhalgh said. “My daughter did finally get me an appointment, but it’s on April 7.” Exasperation is building among seniors across the United States, many of whom are encountering similar roadblocks trying to line up a potentially life-saving vaccination, experts say. ‘No good stories’ In much of the country, seniors don’t know where to call, when to call, how to get an appointment. “There’s a great deal of frustration,” said Tricia Neuman, senior vice president of the Kaiser Family Foundation. “I was just on a call with about a dozen people from different parts of the country, and people were talking about their parents’ experiences. Everybody had a different story to tell, but nobody had a good story to tell,” Neuman added. “Nobody had…  read on >  read on >

As more infectious coronavirus variants first detected in Britain and South Africa circulate globally, President Joe Biden plans to bar travel by non-citizens into the United States from South Africa. A White House official said Sunday that the South Africa travel ban would go into effect on Jan. 30 and that an existing ban would be extended on non-citizen travelers from Europe and Brazil, The New York Times reported. The U.S. Centers for Disease Control and Prevention recently warned that the British coronavirus variant could become the dominant source of infections in the United States by March and would likely trigger surges in cases and deaths. As of Monday, the British variant has been detected in 22 states, the CDC reported. The agency has also announced a new policy that requires all arriving international air passengers, regardless of vaccination status, to be tested for the coronavirus within three days of their departure for the United States, and to provide written documentation of their test results or proof of having recovered from COVID-19. The South African coronavirus variant has yet to be detected in the United States, but small studies published last week show that it is less susceptible to antibodies created by natural infection or by vaccines made by Pfizer and Moderna, which have both been authorized for emergency use in the United States, the…  read on >  read on >

Full doses of blood thinners can benefit patients hospitalized with COVID-19, but the severity of their illness matters, researchers say. The new global analysis found that hospitalized patients with moderate COVID-19 may benefit from the drugs’ clot-preventing powers, but patients with illness so severe it requires admission to an intensive care unit may not. “SARS-CoV-2 infection can increase the risk for developing blood clots by causing a significant inflammatory response in the body,” explained Dr. Aeshita Dwivedi, a cardiologist at Lenox Hill Hospital in New York City. “These blood clots can further lead to debilitating and life-threatening conditions like heart attacks, strokes or pulmonary embolisms,” said Dwivedi, who wasn’t involved in the new study. She said the new data “has demonstrated that a higher dose of blood thinners, in addition to being safe, reduced the need for life support and possibly even death” in moderately ill patients in the hospital. Early in the COVID-19 pandemic, doctors worldwide noted that COVID-19 patients had high rates of blood clots and inflammation that led to complications, such as lung failure, heart attack and stroke. At the time, it wasn’t known whether providing COVID-19 patients with high doses of blood thinners would be safe and effective. Last December, the same group of researchers released findings showing that routine use of full-dose blood thinners in more critically ill COVID-19 patients…  read on >  read on >

Giving melanoma patients a “personalized” vaccine can prompt an anti-tumor immune response that lasts for years, an early study finds. The study involved just eight patients with advanced melanoma, the deadliest form of skin cancer. But it builds on earlier work showing it is possible to spur the immune system to respond to an individual’s unique tumor. All eight patients underwent standard surgery for their melanoma, but were considered high risk for a recurrence. So researchers gave them an experimental vaccine called NeoVax. Unlike traditional vaccines, it is not a one-size-fits-all jab. Each patient’s vaccine was customized based on key “neoantigens” — abnormal proteins — that were present on their tumor cells. Even though those proteins are foreign, the immune system is not able, on its own, to generate a major response against them. “The problem is, the tumor itself doesn’t present enough of a danger signal,” said Dr. Patrick Ott, one of the researchers on the new study. Beyond that, tumors have various ways of eluding the body’s defenses, explained Ott, of the Dana-Farber Cancer Institute in Boston. The idea behind NeoVax is to present the immune system with the tumor neoantigens so it can generate a focused T cell response against them. T cells are immune system sentries that can find and destroy cancer cells. In earlier work, Ott and his colleagues found…  read on >  read on >

Low-dose aspirin may help some people curb their risk of developing colon cancer — but not if they wait until age 70 to start, a large, new study suggests. Researchers found that when people began using aspirin in their 50s or 60s, their risk of developing colon cancer after age 70 was trimmed by 20%. There was no such benefit, however, among people who began using aspirin at age 70 or later. No one is saying all middle-aged people should rush to take low-dose aspirin, experts cautioned. In fact, the U.S. Preventive Services Task Force recommends low-dose aspirin (usually 81 mg a day) for only a select group: People in their 50s who have at least a 10% risk of suffering a heart attack or stroke in the next 10 years. The rationale is that long-term aspirin use carries a risk of bleeding in the gut or the brain. But for those middle-aged adults, the risk is outweighed by the benefits — namely, reduced odds of both cardiovascular disease and colon cancer. With older adults, the benefits of starting aspirin are less clear. So the task force — a government-funded panel of medical experts — suggests people in their 60s talk to their doctor about the pros and cons. For people in their 70s, the aspirin question gets murkier. And a 2018 clinical trial fueled…  read on >  read on >

Talk therapy for new mothers with postpartum depression may also benefit their babies’ brains, Canadian researchers say. “We found that after their moms were treated that their infant’s brain activity normalized to the levels seen in our healthy infants,” said study co-author Ryan Van Lieshout, an associate professor of psychiatry and behavioral neuroscience at McMaster University in Hamilton, Ontario. The study included 40 infants of women with postpartum depression and 40 infants of non-depressed mothers. The mothers with postpartum depression received nine weeks of group cognitive behavioral therapy. This type of therapy aims to help patients change destructive thought patterns. Their infants were assessed before therapy began and nine weeks later. That included having mothers and their partners complete a questionnaire on their infants’ behavior. Cognitive behavioral therapy not only helped the mothers, but also led to improvements in their infants’ nervous and cardiovascular systems, as well as their emotions and behavior, according to the researchers. It is known that children of women with postpartum depression have changes in brain function that increase their risk of emotional and behavioral problems later in life, but it wasn’t known if treating the mother’s postpartum depression could reduce the risk. “We believe that this is the first time that anyone has shown that treating moms’ postpartum depression can lead to healthy changes in the physiology of the brains…  read on >  read on >

The explosive rise in use of alcohol-based hand sanitizers during the COVID-19 pandemic has had a dangerous, unintended consequence: eye injuries among children. Using data from French poison control and a children’s hospital in Paris, researchers reported that accidental eye injuries to kids under age 18 shot up sevenfold during a five-month period last year, compared to 2019. Eye injury due to hand sanitizer exposure “is a known complication,” said Dr. Sonal Tuli, a clinical spokeswoman for the American Academy of Ophthalmology (AAO) who reviewed the study findings. “This is a concern not just for children but also adults and health care workers,” Tuli said. “To my knowledge, there have been no recent similar studies in the U.S., but I suspect there are similar injuries occurring here, too.” The new study was published online Jan. 21 in JAMA Ophthalmology. Hand sanitizers consist mainly of ethanol or isopropyl alcohol (60% to 95%), which are toxic to delicate structures like eyes, noted Dr. Sonam Yangzes, a consultant in the division of lens, cornea and refractive services for the Grewal Eye Institute in Chandigarh, India. As such, exposure to sanitizers “may lead to blindness, due to development of corneal ulcer or melt,” said Yangzes, who co-wrote an editorial that accompanied the study. Increased use of the products during the COVID-19 pandemic has made “children more vulnerable to eye…  read on >  read on >